Blog – Omphalos Lifesciences

Joint Research Agreement with Institut Pasteur Korea

Omphalos Lifesciences December 19, 2025

We are pleased to announce a 𝐉𝐨𝐢𝐧𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐀𝐠𝐫𝐞𝐞𝐦𝐞𝐧𝐭 with Institut Pasteur Korea (IPK), a world-leading center for infectious disease research and a state-of-the-art scientific hub within the global Pasteur Network. IPK is internationally recognized for its advanced research infrastructure, including BSL-3 laboratory capabilities and high-throughput screening platforms that support

Omphalos Secures BARDA Support for Pathogen-Agnostic Antimicrobial Strategy Simulation

Omphalos Lifesciences December 11, 2025

We are excited to share that Omphalos Lifesciences Inc has been selected to receive non-dilutive support from Biomedical Advanced Research and Development Authority (BARDA) through MATTER’s Paratus digital health program! 👉 Read the full article on MATTER’s website This support enables us to advance our 𝐩𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐚𝐛𝐥𝐞 𝐯𝐢𝐫𝐭𝐮𝐚𝐥 𝐜𝐞𝐥𝐥 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 by

Omphalos Lifesciences Wins Award at PARATUS Digital Health Accelerator Showcase

Omphalos Lifesciences October 1, 2025

Omphalos is honored to have been selected as one of the award recipients at the Paratus Digital Health Accelerator final showcase. 👉 Read the full article and videos on MATTER’s website We extend our sincere thanks to MATTER, the mentors, and our fellow innovators (Ad Astra Diagnostics, Inc. and SHADDARI

Omphalos Selected for BARDA-Backed Paratus Digital Health Accelerator

Omphalos Lifesciences July 11, 2025

We’re excited to share that Omphalos Lifesciences Inc has been selected for MATTER’s Paratus Digital Health Accelerator, part of the Biomedical Advanced Research and Development Authority (BARDA) Accelerator Network! 👉 Read the full article on MATTER’s website At Omphalos, we believe that programming biology is the key to building fast,

NVIDIA Inception Program

Omphalos Lifesciences June 9, 2025

We’re excited to share that Omphalos Lifesciences Inc is now part of the NVIDIA Inception Program! Our work sits at the intersection of #biology and #computation. We’re building a new #foundation and #infrastructure for life sciences, one where cells can be written, simulated, and optimized like software. Our #VirtualCell technology

Bacterial Chemotaxis Part 2

Omphalos Lifesciences May 3, 2024

We previously published a post about a model of bacterial chemotaxis in which we discussed the chemotaxis behavior in an individual E. coli, its biological function, and the mechanical forces that drive it. Using a model described by Dr. Brian Ingalls, we provided a program that would simulate bacterial chemotaxis

Specification for Biosystems in the Presence of Unknowns

Omphalos Lifesciences April 5, 2024

In our last post we discussed how two abstractions in L++ can be implemented to create highly specific and detailed descriptions of biosystems; however, before any design is implemented we should know how the final product should be assembled and how it should behave when it is complete. L++ allows

Two abstractions of L++ enables the precise description of biosystems

Omphalos Lifesciences March 1, 2024

At first glance any system can look like a complicated web of components; however, it’s important to not get bogged down in every tiny detail. If you were given a recipe, you would only be required to know basic details like which ingredients to use, and how to prepare and

Life in light of atoms, molecules, and proteins

Omphalos Lifesciences February 2, 2024

What we now call Biology used to be considered “magic”. Before Germ Theory, developed in the mid-nineteenth century, diseases were often associated with demons and other malicious creatures of myth. Take tuberculosis for example, the disease that gave rise to the myth of the vampire. The more we have learned

Bacterial Chemotaxis, Part 1

Omphalos Lifesciences January 5, 2024

All around us, there is a world of microorganisms that is as alien in appearance as an extraterrestrial from an old sci-fi movie. E. coli is a rod-shaped bacterium that is a mere 1-2 micrometers long. Just like larger animals such as humans, it is imperative that E. coli move and respond to their

News & Insights

Stay up to date with company news, product updates, and industry perspectives.